Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Nu Holdings Ltd (NU) Price & Performance

GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.

The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.

NU Holdings (NU) trades at $15.58, down 2.69% on the day, as the stock consolidates near key technical levels. The company demonstrates strong fundamental momentum with revenue growing from $3.0B in 2022 to $10.6B in 2025 and net income turning positive to $2.9B. Recent news highlights acquisition speculation regarding Monzo, though the company has denied pursuing a transaction. Technical indicators show a bullish moving average signal but neutral oscillators, with RSI suggesting potential overbought conditions.

The outlook remains positive given NU's expanding customer base and profitability trajectory, with analyst consensus favoring Buy ratings (56.5%) and a $16.53 price target representing 6% upside. Key risks include credit quality concerns from rising delinquencies and the stock's premium valuation multiples. The company's operational efficiency and Latin American expansion provide growth catalysts, though investors should monitor execution against earnings expectations.